Patheon Announces Initial Public Offering
Patheon launches initial public offering to repay outstanding notes and expenses.
Patheon announced on July 11, 2016, the commencement of the initial public offering of 30,487,805 of its ordinary shares for an expected price between $19.00 and $22.00 per share.
According to a statement, the company intends to use the proceeds of the sale and cash on hand to repay its outstanding $550 million of Senior PIK Toggle Notes, and pay related fees, expenses, and accrued interest.
The company is selling 25,609,756 ordinary shares and a selling stockholder is selling 4,878,049 ordinary shares. Patheon will not receive any proceeds from the sale of ordinary shares by the selling stockholder.
The ordinary shares of the company will be listed on the New York Stock Exchange under the symbol "PTHN".
In June 2015, Patheon filed a registration statement with the Securities and Exchange Commission (SEC) related to a proposed initial public offering of its common stock.
Source: Patheon
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
